Previous close | 6.20 |
Open | 6.20 |
Bid | 6.60 |
Ask | 7.50 |
Strike | 28.00 |
Expiry date | 2024-08-16 |
Day's range | 6.20 - 6.20 |
Contract range | N/A |
Volume | |
Open interest | 1 |
New Findings from Myriad Genetics Reveal One-Third of Americans Say Election Season Affects Their Mental HealthSALT LAKE CITY, June 24, 2024 (GLOBE NEWSWIRE) -- A significant 40% of Americans report feeling ‘depressed and/or anxious’ around the election season according to the latest GeneSight® Mental Health Monitor: Special Election Series, a nationwide survey from Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in genetic testing and precision medicine. “The results of the Special Election Surve
Key Insights Using the 2 Stage Free Cash Flow to Equity, Myriad Genetics fair value estimate is US$34.23 Current share...
Myriad Genetics (MYGN) collaborates with GSK to improve access to HRD diagnostic testing for HGSOC patients.